Weight change does not identify which tissues changed. DXA adds useful body-composition information, but its lean-mass measurement should not be renamed “muscle strength.” Primary substudy
Study observations and correction
This SURMOUNT-1 substudy included 160 participants with paired scans: 124 receiving pooled tirzepatide doses and 36 receiving placebo. At 72 weeks, fat and lean mass had both decreased. Approximately three quarters of the weight lost was fat and one quarter lean mass in both groups. A published correction changed Figure 4 axis units from percentages to kilograms. Study, correction
What the scan can and cannot establish
DXA lean mass is a body-composition category, not a direct count of functioning skeletal-muscle fibers. A change in that category cannot by itself establish better or worse physical performance. Strength, mobility, symptoms, and relevant tissue measurements would answer additional questions.
Proportions also need their denominator. “One quarter of weight lost” is not the same as “one quarter of starting lean mass.” Confusing those statements can dramatically exaggerate the finding. Absolute changes and baseline amounts should be shown together when communicating individual compartments.
The paired-scan sample is smaller than the parent trial. Review should establish how participants entered the substudy, why scans were missing, and whether those with paired scans differed from those without them. Randomization in a parent study does not remove every concern introduced by analysis of a selected subset.
The figure correction is material because kilograms and percentages answer different questions. Any plot-derived numerical summary must use the corrected units rather than reproducing the original label.
This report adds a body-composition question to SURMOUNT-1; it is not independent replication of the parent weight-loss trial. It does not establish a universal muscle-preservation claim or quantify an individual's functional risk. Those interpretations require appropriately measured functional outcomes and a broader clinical assessment.
Frequently asked questions
Did everyone in SURMOUNT-1 have paired DXA data?
No.
Were both fat and lean mass reduced?
Yes.
Does lean mass mean muscle strength?
No.
Is the fraction of weight lost a fraction of baseline tissue?
No; those denominators differ.
Was a figure corrected?
Yes, its axis units.
Is this an independent new trial?
No, it is a substudy.
What additional outcomes would help assess function?
Direct strength and physical-performance measurements.